ArticleEuropean journal of clinical pharmacology2014

CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients.

Jasna Klen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.